E-LIB Suche - Ergebnisse für: Erlichman, Charles

1

A phase 2 study of MK‐2206 in patients with incurable adeno..:

Ho, Alan L. ; Foster, Nathan R. ; Deraje Vasudeva, Shyamprasad...
Cancer. 130 (2023) 5 - p. 702-712 , 2023

Link: https://doi.org/10.1002/..

2

Phase I study of cediranib, an oral VEGFR inhibitor, in com..:

Hubbard, Joleen M. ; Yin, Jun ; Schenk, Erin L....
Investigational New Drugs. 40 (2021) 1 - p. 115-123 , 2021

Link: https://doi.org/10.1007/..

3

Clinicopathological and Molecular Characteristics of Early-..:

Jin, Zhaohui ; Dixon, Jesse G ; Fiskum, Jack M...
JNCI: Journal of the National Cancer Institute. 113 (2021) 12 - p. 1693-1704 , 2021

Link: https://doi.org/10.1093/..

4

Phase 1 trial of Vismodegib and Erlotinib combination in me..:

McCleary-Wheeler, Angela L. ; Carr, Ryan M. ; Palmer, Shanique R....
Pancreatology. 20 (2020) 1 - p. 101-109 , 2020

Link: https://doi.org/10.1016/..

5

Targeting of the Hedgehog/GLI and mTOR pathways in advanced..:

Carr, Ryan M. ; Duma, Narjust ; McCleary-Wheeler, Angela L....
Pancreatology. 20 (2020) 6 - p. 1115-1122 , 2020

Link: https://doi.org/10.1016/..

6

A phase II study of the orally administered negative enanti..:

Xie, Hao ; Yin, Jun ; Shah, Manisha H....
Investigational New Drugs. 37 (2019) 4 - p. 755-762 , 2019

Link: https://doi.org/10.1007/..

7

Akt inhibitor MK‐2206 in combination with bendamustine and ..:

Larsen, Jeremy T. ; Shanafelt, Tait D. ; Leis, Jose F....
American Journal of Hematology. 92 (2017) 8 - p. 759-763 , 2017

Link: https://doi.org/10.1002/..

8

A phase I study of cilengitide and paclitaxel in patients w..:

Haddad, Tufia ; Qin, Rui ; Lupu, Ruth...
Cancer Chemotherapy and Pharmacology. 79 (2017) 6 - p. 1221-1227 , 2017

Link: https://doi.org/10.1007/..

9

Combination epigenetic therapy in metastatic colorectal can..:

Azad, Nilofer S. ; el-Khoueiry, Anthony ; Yin, Jun...
Oncotarget. 8 (2017) 21 - p. 35326-35338 , 2017

Link: https://doi.org/10.18632..

10

A hierarchical Bayesian design for randomized Phase II clin..:

Yin, Jun ; Qin, Rui ; Sargent, Daniel J...
Journal of Biopharmaceutical Statistics. 28 (2017) 3 - p. 451-462 , 2017

Link: https://doi.org/10.1080/..

11

Phase II trial of gemcitabine and tanespimycin (17AAG) in m..:

Pedersen, Katrina S. ; Kim, George P. ; Foster, Nathan R....
Investigational New Drugs. 33 (2015) 4 - p. 963-968 , 2015

Link: https://doi.org/10.1007/..

12

Phase I trial of FOLFIRI in combination with sorafenib and ..:

Hubbard, Joleen M. ; Kim, George ; Borad, Mitesh J....
Investigational New Drugs. 34 (2015) 1 - p. 96-103 , 2015

Link: https://doi.org/10.1007/..

13

Safety and activity of temsirolimus and bevacizumab in pati..:

Merchan, Jaime R. ; Qin, Rui ; Pitot, Henry...
Cancer Chemotherapy and Pharmacology. 75 (2015) 3 - p. 485-493 , 2015

Link: https://doi.org/10.1007/..

14

A Multicenter Phase 2 Trial of Pazopanib in Metastatic and ..:

Bible, Keith C. ; Suman, Vera J. ; Molina, Julian R....
The Journal of Clinical Endocrinology & Metabolism. 99 (2014) 5 - p. 1687-1693 , 2014

Link: https://doi.org/10.1210/..

15

A phase II trial of bevacizumab plus temsirolimus in patien..:

Knox, Jennifer J. ; Qin, Rui ; Strosberg, Jonathan R....
Investigational New Drugs. 33 (2014) 1 - p. 241-246 , 2014

Link: https://doi.org/10.1007/..